Anticoagulant Reversal Drugs Market Likely to Inflict Positive Growth Trends

Posted by Arslan on February 11th, 2020

Application of anticoagulant reversal drugs has increased in the modern days for treating health conditions that have the potential to be life-threatening. Manufacturers in the global anticoagulant reversal drugs market have sensed the increasing demand and are diverting their focus towards research and development activities to gain better hold of the market. This creates a very robust and efficient pipeline in the reversal drugs market in different regions including North America and Europe as major market players are concentrated in these regions. Moreover, governments of these regions financially aid the therapeutics production in anticoagulant reversal drugs market which encourages the stake holders to introduce novel drugs. Major drugs get fast track approvals which allows them to reach greater consumer segment in shorter period of time.

Idarucizumab Is Highly Preferred Drug

Favorable government initiatives in different developed countries end up making the global market environment very conducive. High prices of these reversal drugs prompt the manufacturers on global and regional level to fasten up production of generic drugs. The global market is highly fragmented in nature and generates plethora of opportunities to accommodate regional, local and global players.

Idarucizumab is one of the highly preferred anticoagulant reversal drug that has witnessed significant increment in its sales. Its sale increased by 19% from the year 2018 to 2019. The immediate surge in the sale of the drug can be contributed to the absence of equivalent substitute drug in market. However, latest Fact.MR report predicts that its sale will decrease by 11% by the year 2026 owing to the tough competition from Andexxa which was government approved in the year 2018. Preference for Andexxa has steeply increased over Idarucizumab for the former being an orphan drug. Fact.MR report projects that the popularity for Andexxa will increase exponentially in future due to the absence of equally effective drug in the global market.

You can Request an Example Copy from here - https://www.factmr.com/connectus/sample?flag=S&rep_id=4338

The healthcare team at Fact.MR assists clients with unique business intelligence needs on a global level. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analysed the healthcare industry to a micro-level across 50+ countries for over a decade. The team provides end-to-end research and consulting services to help keep clients at the top of the game. Reach out to us to know how we can help.